Choleystyramine Light has 13 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Digitalis Glycosides, Andthiazide, Estrogens. Patients taking Choleystyramine Light should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 13
- Major
- 1
- Moderate
- 11
Major (1)
- Choleystyramine Light + Digitalis Glycosides— Cholestyramine may reduce digitalis absorption; discontinuance could pose hazard if drug was titrated to maintenance lev…
Moderate (11)
- Choleystyramine Light + Andthiazide— Cholestyramine may delay or reduce absorption of thiazide diuretics (acidic).
- Choleystyramine Light + Estrogens— Cholestyramine may delay or reduce absorption of estrogens.
- Choleystyramine Light + Levothyroxine— Cholestyramine may delay or reduce absorption of thyroxine.
- Choleystyramine Light + Penicillin G— Cholestyramine may delay or reduce absorption of penicillin G.
- Choleystyramine Light + Phenobarbital— Cholestyramine may delay or reduce absorption of phenobarbital.
- Choleystyramine Light + Phenylbutazone— Cholestyramine may delay or reduce absorption of phenylbutazone.
- Choleystyramine Light + Phosphate-Binding Agents— Cholestyramine may interfere with the absorption of oral phosphate supplements.
- Choleystyramine Light + Propranolol— Cholestyramine may delay or reduce absorption of propranolol (basic).
- Choleystyramine Light + Tetracycline— Cholestyramine may delay or reduce absorption of tetracycline.
- Choleystyramine Light + Thyroid— Cholestyramine may delay or reduce absorption of thyroid preparations.
- Choleystyramine Light + Warfarin— Cholestyramine may delay or reduce absorption of warfarin.